TP, B., JR, C., ME, R., JR, H., JM, K., D, M., . . . JJ, S. (2012). Discovery of LY2457546: A multi-targeted anti-angiogenic kinase inhibitor with a novel spectrum of activity and exquisite potency in the acute myelogenous leukemia-Flt-3-internal tandem duplication mutant human tumor xenograft model. Investigational new drugs, 30(3), 936. https://doi.org/10.1007/s10637-011-9640-6
Chicago Style (17th ed.) CitationTP, Burkholder, et al. "Discovery of LY2457546: A Multi-targeted Anti-angiogenic Kinase Inhibitor with a Novel Spectrum of Activity and Exquisite Potency in the Acute Myelogenous Leukemia-Flt-3-internal Tandem Duplication Mutant Human Tumor Xenograft Model." Investigational New Drugs 30, no. 3 (2012): 936. https://doi.org/10.1007/s10637-011-9640-6.
MLA (9th ed.) CitationTP, Burkholder, et al. "Discovery of LY2457546: A Multi-targeted Anti-angiogenic Kinase Inhibitor with a Novel Spectrum of Activity and Exquisite Potency in the Acute Myelogenous Leukemia-Flt-3-internal Tandem Duplication Mutant Human Tumor Xenograft Model." Investigational New Drugs, vol. 30, no. 3, 2012, p. 936, https://doi.org/10.1007/s10637-011-9640-6.
